Skip to main content
Clinical Trials/TCTR20221027002
TCTR20221027002
Not yet recruiting
Phase 2

The effect of Moringa oleifera leaves on platelet aggregation in healthy adults and hypertensive patients.

Faculty of Medicine Ramathibodi Hospital0 sites40 target enrollmentStarted: October 27, 2022Last updated:

Overview

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Faculty of Medicine Ramathibodi Hospital
Enrollment
40

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
40 Years to 59 Years (—)
Sex
All

Inclusion Criteria

  • 1\. age 40\-59 years
  • 2\. Systolic blood pressure \< 140 mmHg and diastolic blood pressure \< 90 mmHg for healthy population group
  • 3\. Systolic blood pressure 140\-159 mmHg and diastolic blood pressure 90\-99 mmHg for hypertensive group

Exclusion Criteria

  • 1\. smoking
  • 2\. pregnancy
  • 3\. medication or herbal use that affects platelet function
  • 4\. medical conditions or underlying diseases that affects platelet function
  • 5\. underlying diseases: cardiovascular diseases, chronic lung diseases, chronic liver diseases, chronic kidney diseases, and cancer, etc.
  • 6\. participants' voluntary withdrawal of consent

Investigators

Sponsor
Faculty of Medicine Ramathibodi Hospital

Similar Trials